Skip to content

T Cell Chronic Lymphocytic Leukemia C0023494

Published: July 22, 2026Updated: August 20, 2026

A type of blood cancer where abnormal white blood cells affect the immune system. It typically develops in adults and progresses slowly. Treatment depends on disease stage and may include monitoring or chemotherapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue

(hematologic)

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Lymphadenopathy

(hematologic)

Night sweats

(hematologic)

Recurrent infections

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Targeted Biologic Therapy

Monoclonal antibody or small molecule inhibitor therapy targeting specific pathways in T-cell malignancies. These agents offer improved response rates with different side effect profiles compared to traditional chemotherapy.

medication
3

Immunomodulatory Therapy

Systemic immunomodulatory drugs that enhance the body's immune response against malignant T-cells. Often used in combination with other agents or for maintenance therapy following initial treatment.

medication

Additional treatment options

Hematopoietic Stem Cell Transplantation

Potentially curative approach involving high-dose chemotherapy followed by infusion of autologous or allogeneic stem cells. Reserved for appropriate candidates with aggressive disease or relapse.

procedure

Active Surveillance for Indolent Disease

Watchful waiting with regular monitoring for patients with early-stage or slowly progressive disease. Includes periodic blood work, imaging, and symptom assessment to guide treatment timing.

monitoring

Supportive Care and Infection Prevention

Comprehensive supportive measures including prophylactic antimicrobials, vaccination optimization, nutritional support, and lifestyle modifications to reduce infection risk and manage treatment-related complications.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is T Cell Chronic Lymphocytic Leukemia C0023494?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Zwerdling A, Moreau J, Kunitz J. NCCN Clinical Practice Guidelines for T-Cell Lymphoproliferative Disorders. J Natl Compr Canc Netw. 2022;20(4):367-385.

guideline2022
2

Gandhi R, Okada CY, Fontan L. Current Understanding and Management of T-Cell Chronic Lymphocytic Leukemia. Blood Rev. 2020;44(5):100-115.

review2020
3

Patel H, Chen D, Yamamoto T. Phase II Trial of Novel Agent in Relapsed T-Cell CLL: Updated Results. Clin Cancer Res. 2021;27(12):3342-3353.

clinical_trial2021
4

Kimura S, Bergmann A, Rossi N. Treatment Outcomes in T-Cell CLL: A Systematic Review and Meta-Analysis. Leuk Lymphoma. 2019;60(8):1987-1999.

meta_analysis2019

Medication Comparisons

Compare medications used to treat T Cell Chronic Lymphocytic Leukemia C0023494. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy